ETR Stock Overview
Engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Etropal AD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | лв4.20 |
| 52 Week High | лв4.50 |
| 52 Week Low | лв4.00 |
| Beta | 0.099 |
| 1 Month Change | -2.33% |
| 3 Month Change | 0% |
| 1 Year Change | -4.55% |
| 3 Year Change | -30.00% |
| 5 Year Change | -28.21% |
| Change since IPO | -30.00% |
Recent News & Updates
Recent updates
We Think Etropal AD (BUL:ETR) Can Stay On Top Of Its Debt
Apr 13
Etropal AD (BUL:ETR) Is Making Moderate Use Of Debt
Mar 24Etropal AD (BUL:ETR) Use Of Debt Could Be Considered Risky
May 11We Think Etropal AD (BUL:5EO) Is Taking Some Risk With Its Debt
Jan 26
Should Weakness in Etropal AD's (BUL:5EO) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Dec 04Shareholder Returns
| ETR | BG Medical Equipment | BG Market | |
|---|---|---|---|
| 7D | 2.4% | 3.1% | -0.2% |
| 1Y | -4.5% | 16.7% | 7.6% |
Return vs Industry: ETR underperformed the BG Medical Equipment industry which returned 16.7% over the past year.
Return vs Market: ETR underperformed the BG Market which returned 7.6% over the past year.
Price Volatility
| ETR volatility | |
|---|---|
| ETR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in BG Market | 6.9% |
| 10% least volatile stocks in BG Market | 2.5% |
Stable Share Price: ETR's share price has been volatile over the past 3 months compared to the BG market.
Volatility Over Time: Insufficient data to determine ETR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 98 | Lyubomir Kolchev | www.etropal.eu |
Etropal AD engages in the research, development, and manufacture of disposable medical devices for dialysis in Bulgaria. The company offers capillary dialyzers; arterial-venous(A/V) blood line sets; procedure kits; and A/V fistula needles. The company was founded in 1976 and is headquartered in Etropole, Bulgaria.
Etropal AD Fundamentals Summary
| ETR fundamental statistics | |
|---|---|
| Market cap | лв21.00m |
| Earnings (TTM) | лв81.00k |
| Revenue (TTM) | лв15.24m |
259.3x
P/E Ratio1.4x
P/S RatioIs ETR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ETR income statement (TTM) | |
|---|---|
| Revenue | лв15.24m |
| Cost of Revenue | лв10.45m |
| Gross Profit | лв4.79m |
| Other Expenses | лв4.71m |
| Earnings | лв81.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.016 |
| Gross Margin | 31.45% |
| Net Profit Margin | 0.53% |
| Debt/Equity Ratio | 39.1% |
How did ETR perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 06:01 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Etropal AD is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|